The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ethyl-5-((1H-pyrrol-2-yl)methylene)-2-((3-nitrophenyl)amino)-4-oxo-4,5-dihydrothiophene-3-carboxylate ID: ALA5184382
PubChem CID: 168282991
Max Phase: Preclinical
Molecular Formula: C18H15N3O5S
Molecular Weight: 385.40
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)C1=C(Nc2cccc([N+](=O)[O-])c2)S/C(=C\c2ccc[nH]2)C1=O
Standard InChI: InChI=1S/C18H15N3O5S/c1-2-26-18(23)15-16(22)14(10-11-6-4-8-19-11)27-17(15)20-12-5-3-7-13(9-12)21(24)25/h3-10,19-20H,2H2,1H3/b14-10-
Standard InChI Key: QHYRGIPMYIQMSV-UVTDQMKNSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
-0.8095 -0.4343 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.4770 0.0505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2220 0.8352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3970 0.8352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1421 0.0505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6545 -0.1629 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8680 -0.9597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6647 -1.1734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8769 -1.9680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2934 -2.5514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5002 -2.3405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2823 -1.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0153 1.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3970 2.2638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0153 2.9782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8402 2.9782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8402 1.5495 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6344 1.5495 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.2737 -0.1629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4871 -0.9597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9684 -1.6004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4173 -2.2918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2137 -2.0785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2569 -1.2551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6736 -2.1815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8871 -2.9782 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2569 -1.5982 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
5 6 1 0
6 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
11 10 1 0
12 11 2 0
7 12 1 0
4 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
13 17 2 0
3 18 2 0
2 19 2 0
19 20 1 0
21 20 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 1 0
25 9 1 0
25 26 1 0
25 27 2 0
M CHG 2 25 1 26 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.40Molecular Weight (Monoisotopic): 385.0732AlogP: 3.47#Rotatable Bonds: 6Polar Surface Area: 114.33Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.67CX Basic pKa: ┄CX LogP: 3.67CX LogD: 3.67Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.26Np Likeness Score: -1.40
References 1. Hwang J, Qiu X, Borgelt L, Haacke N, Kanis L, Petroulia S, Gasper R, Schiller D, Lampe P, Sievers S, Imig J, Wu P.. (2022) Synthesis and evaluation of RNase L-binding 2-aminothiophenes as anticancer agents., 58 [PMID:35152173 ] [10.1016/j.bmc.2022.116653 ] 2. Duvauchelle V, Meffre P, Benfodda Z.. (2022) Recent contribution of medicinally active 2-aminothiophenes: A privileged scaffold for drug discovery., 238 [PMID:35696863 ] [10.1016/j.ejmech.2022.114502 ]